Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 31, 2019
Patent Application Number
15952073
Date Filed
April 12, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDM1A, methods of increasing gamma globin gene expression, and methods to induce differentiation of cancer cells in a human or animal subject are also provided for the treatment of diseases such as acute myelogenous leukemia.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
